Abstract
Streptococcus pneumoniae is the agent responsible for infections such as pneumonia, otitis media, and meningitis. Among virulence factors, the Pneumococcal surface protein A (PspA) has been shown to be immunogenic and protective in mice, and is thus a good vaccine candidate. PspA has been classified into 6 clades and 3 families. Initially, pspA fragments, clades 1 and 3, were cloned into the pAE-6His expression vector. Proteins were expressed in Escherichia coli BL21(DE3) and purified by affinity and anion exchange chromatographies, with a yield of 11 mg/l of culture. Due to plasmid instability in E. coli, another construct using pspA1 was obtained based on pET-37b(+), which was shown to be stable in E. coli and increased the yield ∼3-fold. Our results show good conditions for scale-up. Sera from immunized mice recognized PspA in total extracts of S. pneumoniae strains: anti-rPspA1p sera recognized native PspA clades 1 (+++), 2 (++) and 4 (+) and anti-rPspA3p sera recognized PspA clades 1 (+), 2 (+), 3 (+++) and 4 (+). The cross-reactivity pattern obtained confirms the notion that proteins from both families should be included for development of a broad-coverage vaccine; lower-cross reactivity between rPspAs of family 2 indicates that it may be necessary to include 2 proteins from this family.
Similar content being viewed by others
References
Prescott, L. M., Harley, J. P., & Klein, D. A. (1996). Microbiology. USA: VMC BROWN Publishers.
Briles, D. E., Tart, R. C., Swiatlo, E., Dillard, J. P., Smith, P., Benton, K. A., Ralph, B. A., Brooks-Walter, A., Crain, M. J., Hollingshead, S. K., & McDaniel, L. S. (1998). Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clinical Microbiology Reviews, 11, 645–657.
Black, S., Shinefield, U., Ray, P., Edwi, L., & Fireman, B. (1998). Efficacy of heptavalente conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Results of northern California Keiser Permanent efficacy trial. ICAAC Abstracts, LB-9.
Velasco, A. E., Verheul, A. F. M., Verhoel, J., & Snippe, H. (1995) Streptococcus pneumoniae: Virulence factors, Pathogenesis and Vaccines. Microbiological Reviews 59, 591–603.
McDaniel, L. S., Scott, G., Kearney J. F., & Brilles, D. E. (1984). Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. Journal of Experimental Medicine, 160, 386–397.
Crain, M. J., Waltman, W. D., Turner, J. S., Yother, J., Talkington, D. F., McDaniel, L. S., Gray, B. M., & Brilles, D. E. (1990). Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular seritypes of Streptococcus pneumoniae. Infection and Immunity, 58, 3293–3299.
Waltman, W. D., MaDaniel, L. S., Gray, B. M., & Brilles, D. E. (1990). Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae. Microbial Pathogenesis, 8, 61–60.
ANH-Hue, T. T., Fulgham, R. L., McCrory, M. A., Brilles, D. E., & Szalai, A. J. (1999). Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infection and Immunity, 67, 4720–4724.
Yother, J., & Brilles, D. E. (1992). Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analises. Journal of Bacteriology, 174, 601–609.
Hollingdhead, S. K., Becker, R., & Briles, D. E. (2000). Diversity of PspA: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infection and Immunity ,68, 5889–5900.
Briles, D. E., Hollingshead, S. K., King, J., Swift, A., Braun, P. A., Park, M. K., Ferguson, L. M., Nahm, M. H., & Nabors, G. S. (2000). Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. Journal of Infectious Diseases, 182(6), 1694–1701.
Kolberg, J., Aase, A., Rodal, G., Littlejohn, J. E., & Jedrzejas, M. J. (2003). Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modeling. FEMS, 39, 265–273.
Nabors, G. S., Braun, P. A., Herrmann, D. J., Heise, M. L., Pyle, D. J., Gravenstein, S., Schilling, M., Ferguson, L. M., Hollingshead, S. K., Briles, D. E., & Becker, R. S. (2000). Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine, 18, 1743–1754.
Miyaji, E. N., Ferreira, D. M., Lopes, A. P., Brandileone, M. C., Dias, W. O., & Leite, L. C. (2002). Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. Infection and Immunity, 70, 5086–5090.
Pimenta, F. C., Ribeiro-Dias, F., Brandileone, M. C., Miyaji, E. N., Leite, L. C., & Sgambatti de Andrade, A. L. (2006). Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil. Journal Clinical Microbiology, 44, 2838–2843.
Ramos, C. R., Abreu, P. A., Nascimento, A. L., & Ho, P. L. (2004). A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Brazilian Journal of Médical and Biological Research, 37, 1103–1109.
Lamani, E., McPherson, D. T., Hollingshead, S. K., & Jedrzejas, M. J. (2000). Production, characterization, and crystallization of truncated forms of pneumococcal surface protein A from Escherichia coli. Protein Expression and Purification, 20(3), 379–388.
Jedrzejas, M. J., Hollingshead, S. K., Lebowitz, J., Chantalat, L., Briles D. E., & Lamani, E. (2000). Production and characterization of the functional fragment of pneumococcal surface protein A. Archives of Biochemistry and Biophysics, 373(1), 116–125.
Cebolla, A., Royo, J. L., De Lorenzo, V., & Santero, E. (2002). Improvement of recombinant protein yield by a combination of transcriptional amplification and stabilization of gene expression. Applied and Environmental Microbiology, 68, 5034–5041.
Williams, S. G., Cranenburgh, R. M., Weiss, A. M., Wrighton, C. J., Sherratt, D. J., & Hanak, J. A. (1998). Repressor titration: A novel system for selection and stable maintenance of recombinant plasmids. Nucleic Acids Research, 26, 2120–2124.
Fiedler, M., & Skerra, A. (2001). proBA complementation of an auxotrophic E. coli strain improves plasmid stability and expression yield during fermenter production of a recombinant antibody fragment. Gene, 274, 111–118.
Kolodny, N., Kitov, S., Vassell, M. A., Miller, V. L., Ware, L. A., Fegeding, K., De La Vega, P., Sacci, J. B. Jr., & Lanar, D. E. (2001). Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli. Journal of Chromatography B-Biomedical Science Applications, 762, 77–86.
Acknowledgments
We thank Dr. Mickie Takagi and Dr. Ivan P. Nascimento for assistance during bacterial cultivation and protein analysis. We also thank Ines A. Maurelli, Lourivaldo I. de Souza, Marisa G. Trevelin, Solange R. Silva, Sebastiana V. Oliveira and Sueli G. Pedroza for technical assistance and Fatima A. M. Oliveira for secretarial assistance. This work received financial support from FAPESP, CNPq, and Fundação Butantan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Silva, M., Cabrera-Crespo, J., Sbrogio-Almeida, M.E. et al. Optimizing Expression of Streptococcus pneumoniae Surface Protein a, PspA: Serocross-Reactivity within Families of Antisera Induced Against Clades 1 and 3. Mol Biotechnol 37, 146–154 (2007). https://doi.org/10.1007/s12033-007-0043-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-007-0043-z